NSE IPO 2026: DRHP filed for ₹30,000-crore OFS

NSE takes the first formal step toward listing

The National Stock Exchange of India (NSE) has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on June 17, 2026, restarting a listing process that has been pending for nearly a decade. The filing is the exchange’s most concrete move since an earlier attempt in 2016 that did not go through. The proposed initial public offering (IPO) is widely expected to be one of India’s largest public issues this year. Market estimates cited alongside the filing put the IPO size at around ₹30,000 crore, with some references indicating a ₹30,000 to ₹32,000 crore band. If the issue proceeds at this scale, it would exceed the previous record set by Hyundai Motor India’s ₹27,859 crore IPO in late 2024. The NSE is India’s largest stock exchange and is also described as a leading global derivatives market, which is why the listing is being tracked closely across the capital markets.

What the DRHP indicates about the IPO structure

As described in the draft papers, the NSE IPO is structured entirely as an Offer for Sale (OFS). That means existing shareholders will sell shares, and the company will not raise any fresh capital through a new issue. The DRHP outlines an offer of up to 14.89 crore equity shares, which is also cited as about 149 million shares. This share sale represents approximately 6% of NSE’s equity or paid-up capital. The draft also states that the shares are proposed to be listed on the BSE. With no fresh issue component, the proceeds will go to selling shareholders rather than to NSE.

Deal size signals: ₹30,000 crore and grey market cues

Multiple references around the filing peg the issue size at about ₹30,000 crore, while one estimate puts the number at roughly ₹29,780 crore based on indicative grey market prices of at least ₹2,000. At that level, the implied valuation is described as more than ₹5 trillion, which is over ₹5,00,000 crore. Separately, the unlisted market valuation is also cited as nearly ₹5 lakh crore. Some reports also frame the fundraise in dollar terms at about $1.3 billion, with another estimate around $1.6 billion. The mix of rupee and dollar estimates reflects how observers are triangulating the likely offer size and valuation from secondary market pricing, unlisted trades, and the stated OFS share count.

Who is selling, and who is staying invested

The proposed OFS will be carried out by existing shareholders, with mentions that State Bank of India (SBI) is among key investors expected to sell part of its stake. The draft-linked coverage also points to a broad set of institutional investors, including Singapore’s Temasek and Canada’s national pension fund, who could benefit from the listing. One report estimates that the top ten investors in the share sale could collectively see a windfall of about $1.6 billion based on acquisition prices cited in the draft prospectus. There are also specific estimates of potential gains for certain shareholders, including $198 million for SBI and $119 million for Temasek. At the same time, Life Insurance Corporation of India (LIC), identified as NSE’s single largest shareholder with a 10.72% stake, is reported to not offload any shares in this transaction.

A listing attempt delayed since 2016

The filing draws attention to how long the process has taken. Coverage around the DRHP notes a previous attempt in 2016 that was delayed, and also references regulatory hurdles including the co-location controversy. This context is important because it explains why the June 2026 filing is being treated as a milestone for Indian capital markets. The return to the IPO track also comes at a time when India’s primary market has already seen record-sized deals in the last few years. Hyundai Motor India’s IPO and LIC’s ₹20,557 crore offer are cited as recent benchmarks that the NSE issue could surpass based on current estimates.

Pricing discussions and possible discount to private valuations

Some sources cited alongside the IPO filing indicate that shares could be offered at a discount of 5% to 10% compared with private market valuations. A discussed level is around ₹1,900 per share in those references, while other market cues refer to prices at least around ₹2,000 in grey market indications. The draft-linked reporting also notes that final pricing is typically decided closer to listing after investor engagement. Roadshows are expected to begin within the next couple of months, with mentions that local mutual funds and international investors have shown preliminary interest. These elements indicate the usual sequencing of price discovery rather than a fixed price being available immediately after DRHP filing.

Regulatory path ahead and expected timeline

With the DRHP now filed, SEBI will review the document and later issue observations. One reference describes this review process as typically taking 30 to 90 days. After regulatory approval, the exchange would file the final prospectus with the Registrar of Companies, and then move toward announcing the price band and bidding dates. There is also reporting that places a possible launch window between Navratri and Diwali, around Oct to Nov 2026. While timelines can shift, the key confirmed step at this stage is the DRHP submission and the start of the regulatory review cycle.

Key facts at a glance

Market impact: why this filing matters for investors

The NSE listing is being framed as a landmark because it combines scale with the strategic nature of the asset. For primary market participants, a ₹30,000 crore deal can influence overall IPO liquidity and institutional allocation cycles. For secondary market investors, the filing signals progress toward price discovery in one of India’s most systemically important market infrastructure institutions. The OFS-only structure also matters because it changes the interpretation of proceeds: it is a liquidity event for shareholders rather than a fundraise for exchange expansion. The proposal to list on BSE is another operational detail investors are watching, given NSE’s role in the domestic market structure.

Analysis: what stands out from the DRHP-linked details

Three points stand out from the information circulating alongside the DRHP. First, the size and valuation references suggest a deal that could reset India’s IPO record, with ₹30,000 crore estimates exceeding Hyundai Motor India’s ₹27,859 crore. Second, the offer’s design as a pure OFS of 6% provides clarity on dilution and cash flow, as NSE itself is not expected to receive proceeds. Third, the shareholder mix being discussed, from state-owned banks to global long-term institutions like Temasek and Canada’s pension fund, underlines the breadth of institutional ownership and why the distribution of gains is being tracked. The mention of potential 5% to 10% discounts to private valuations, alongside price talk around ₹1,900 to ₹2,000 per share, highlights how the listed-market price could be calibrated versus the unlisted market.

Conclusion: next milestones after the DRHP

NSE’s June 17, 2026 DRHP filing moves a long-delayed listing plan into the formal regulatory stage. The issue is expected to be a roughly ₹30,000 crore OFS of up to 14.89 crore shares, representing about 6% of equity, with no fresh capital raise and a proposed listing on BSE. The next confirmed step is SEBI’s review and observations, followed by the final prospectus filing and the announcement of the price band and bidding dates. Roadshows are expected in the coming months, and some reports place the IPO window around Oct to Nov 2026, subject to regulatory timelines.